Clinical Trials Directory

Trials / Conditions / Thrombocytopaenia

Thrombocytopaenia

14 registered clinical trials studyying Thrombocytopaenia — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingPreoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.
NCT07278661
Nantes University HospitalPhase 2
RecruitingClinical Efficacy of Platelet Transfusion
NCT06805097
Centre Hospitalier Universitaire de Besancon—
RecruitingSirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586
Peking University First HospitalPhase 4
CompletedCompare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Functi
NCT06761131
Ain Shams University—
TerminatedA Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Sc
NCT02158936
Novartis PharmaceuticalsPhase 3
CompletedA Rollover Study to Provide Continued Treatment With Eltrombopag
NCT01957176
Novartis PharmaceuticalsPhase 4
WithdrawnMilk-only Lactation Study for Patients on Eltrombopag
NCT01055600
GlaxoSmithKlinePhase 4
CompletedEltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
NCT01657552
GlaxoSmithKlinePhase 1
CompletedA Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid
NCT01440374
Novartis PharmaceuticalsPhase 2
CompletedSafety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
NCT01147809
GlaxoSmithKlinePhase 2
CompletedMeta-analysis - Eltrombopag
NCT01235988
GlaxoSmithKline—
CompletedIndirect Comparison Between Eltrombopag & Romiplostim
NCT01236014
GlaxoSmithKline—
CompletedDose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
NCT00358540
GlaxoSmithKlinePhase 1
CompletedSB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherap
NCT00102726
GlaxoSmithKlinePhase 2